• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Imatinib (4)

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
 
Labeling Sections with
Pharmacogenomic
Information
ImatinibOncologyFIP1L1/PDGFRAFIP1L1/PDGFRα fusion
kinase (or CHIC2 deletion) positive
Indications and Usage
Dosage and Administration
Clinical Studies 

 

back to Pharmacogenomic Biomarkers in Drug Labeling